Moreover, while starting an anti-obesity medical treatment, the clinicians should pay particular attention to possible concomitant obesogenic prescription medications, including all drugs in the classes of glucocorticoids, -blockers, antihistamines, as well as selected agents in the classes of antidepressants, antipsychotics, antidiabetics, and contraceptives that are progestin-only [18]
Common combinations include: Semaglutide + BPC-157: BPC-157 supports GI health, which can potentially mitigate some of semaglutide's gastrointestinal side effects while providing its own healing benefits
They require dose escalation over weeks to months, and full therapeutic effects may not appear until you reach the maintenance dose
When used for weight loss, its paired with a reduced calorie diet
Its versions for obesity (e.g., weekly injection) have become widely known